NEXGEL, INC. Embedded Derivative, Fair Value of Embedded Derivative Liability
NEXGEL, INC. (NXGL) had Embedded Derivative, Fair Value of Embedded Derivative Liability of $56.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes
us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability · last filed 2026-08-17
- 2026-06-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $56.00K.
| Period end | Embedded Derivative, Fair Value of Embedded Derivative Liability |
|---|---|
| 2026-06-30 | $56.00K 10-Q · filed 2026-08-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |